作者：
Sturkenboom, Miriam [1]
;
Bahri, Priya [2]
;
Chiucchiuini, Antonella [3]
;
Krause, Tyra Grove [4]
;
Hahne, Susan [5]
;
Khromava, Alena [6]
;
Kokki, Maarit [7]
;
Kramarz, Piotr [8]
;
Kurz, Xavier [9]
;
Larson, Heidi J. [10]
;
de Lusignan, Simon [11]
;
Mahy, Patrick [12]
;
Torcel-Pagnon, Laurence [1]
;
Titievsky, Lina [13]
;
Bauchau, Vincent [10]
作者单位：
European Ctr Dis Prevent & Control, Gustav III S Blvd 40, S-16973 Solna, Sweden
[1]
Univ Surrey, Guildford GU2 7XH, Surrey, England
[2]
Natl Inst Publ Hlth & Environm, POB 1, NL-3720 BA Bilthoven, Netherlands
[3]
GSK Vaccines, Av Fleming 20, B-1300 Wavre, Belgium
[4]
Univ Med Ctr Utrecht, Julius Global Hlth, Heidelberglaan 100, Utrecht, Netherlands
[5]
Takeda Pharmaceut Int GmbH, Thurgauerstr 130, CH-8152 Glattpark, Switzerland
[6]
Sanofi Pasteur, Vaccine Epidemiol & Modelling VEM, Campus SANOFI LYON,14 Espace Henry Vallee, F-69007 Lyon, France
[7]
Pfizer, 219 East 42nd St, New York, NY 10017 USA
[8]
Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Artillerivej 3, DK-2100 Copenhagen, Denmark
[9]
European Med Agcy, 30 Churchill Pl, London E14 5EU, England
[10]
Sciensano, Rue Juliette Wytsmanstr 14, B-1050 Brussels, Belgium
[11]
Sanofi Pasteur, 1755 Steeles Ave W, N York, ON M2R 3T4, Canada
[12]
London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
[13]
发布时间
2021-03-26
换一批
